Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 68001-503

10 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68001-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metoprolol Structure (Metoprololstructure)

Metoprolol Structure (Metoprololstructure)
Chemical structure of Metoprolol Succinate showing the molecular arrangement of the metoprolol moiety on the left and succinate moiety on the right, indicating the extended-release salt form.*
FDA Label Image

Results For Subgroups Figure (Image01)

Results For Subgroups Figure (Image01)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals across three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure. The horizontal axis represents relative risk from 0 to 2. The subgroups listed include geographical location, NYHA class, ejection fraction, etiology, sex, race, myocardial infarction history, diabetes mellitus, hypertension history, and heart rate, with markers indicating favorability toward Metoprolol Succinate Extended-Release Tablets or placebo for each subgroup and outcome.*
FDA Label Image

Rev 052026 (Metoprolol Succ Er Tabs Usp 25mg 100 Tablets Rev 052026)

Rev 052026 (Metoprolol Succ Er Tabs Usp 25mg 100 Tablets Rev 052026)
Label for Metoprolol Succinate extended-release tablets, USP, 25 mg strength, film-coated tablets in a package of 100 tablets. The label includes dosing information, storage instructions, manufacturer details (Alkem Laboratories Ltd. for BluePoint Laboratories), and caution to verify the product dispensed. The label also shows a barcode, space for batch details and a 2D code, and states 'Rx Only.'*
FDA Label Image

Rev 092025 (Metoprolol 25mg 100s Rev 09 25)

Rev 092025 (Metoprolol 25mg 100s Rev 09 25)
Metoprolol Succinate extended-release tablets label for 25 mg strength by BluePoint Laboratories. The label includes a caution to verify the product dispensed, packaging count of 100 tablets, and storage temperature instructions. It shows manufacturer information as Alkem Laboratories Ltd., India, and includes a barcode and revision date of 09/2025.*
FDA Label Image

50mg Rev 05/26 (Metoprolol Succ Er Tabs Usp 50mg 100 Tablets Rev 052026)

50mg Rev 05/26 (Metoprolol Succ Er Tabs Usp 50mg 100 Tablets Rev 052026)
Label for Metoprolol Succinate extended-release tablets, USP, 50 mg strength, oral film-coated tablets. The product is supplied by BluePoint Laboratories and contains 100 tablets per bottle. The label includes caution for product dispensing, storage instructions, manufacturer details (Alkem Laboratories Ltd., India), and barcodes. It also notes the USP equivalent dosage of metoprolol tartrate.*
FDA Label Image

Rev 12/21 (Image02)

Rev 12/21 (Image02)
Label for Metoprolol Succinate Extended-Release Tablets, USP, 50 mg strength, film-coated and oral dosage form. The label indicates 100 tablets in the package, with caution to verify the product dispensed. The label shows the manufacturer as Alkem Laboratories Ltd., India, for BluePoint Laboratories, and includes dosage and storage warnings along with a barcode and NDC 68001-501-00.*
FDA Label Image

Rev 05/2026 (Metoprolol Succ Er Tabs Usp 100mg 100 Tablets Rev 052026)

Rev 05/2026 (Metoprolol Succ Er Tabs Usp 100mg 100 Tablets Rev 052026)
Metoprolol Succinate Extended-Release Tablets USP, 100 mg strength, film-coated tablets in a 100 tablet package. Label shows NDC 68001-502-00, caution to verify product dispensed, and storage instructions. Manufactured by Alkem Laboratories for BluePoint Laboratories. Includes barcode and batch details area with QR code and expiry placeholder.*
FDA Label Image

Rev 12/2021 (Image03)

Rev 12/2021 (Image03)
Metoprolol Succinate 100 mg extended-release tablets label from BluePoint Laboratories. The film-coated tablet contains 95 mg metoprolol succinate equivalent to 100 mg metoprolol tartrate, USP. The label includes dosage form, warnings, storage instructions, manufacturer information for Alkem Laboratories Ltd., India, and package count of 100 tablets. The label is marked Rx Only and features a barcode.*
FDA Label Image

Rev 052026 (Metoprolol Succ Er Tabs Usp 200mg 100 Tablets Rev 052026)

Rev 052026 (Metoprolol Succ Er Tabs Usp 200mg 100 Tablets Rev 052026)
Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg by BluePoint Laboratories. The film-coated tablet pack contains 100 tablets, manufactured by Alkem Laboratories Ltd., India. The label includes NDC 68001-503-00, storage instructions, a caution to verify product dispensed, and a barcode. Dosage details refer to the package insert.*
FDA Label Image

Rev 12/2021 (Image04)

Rev 12/2021 (Image04)
Label for Metoprolol Succinate Extended-Release Tablets, USP, 200 mg strength, film-coated, provided by BluePoint Laboratories. The label indicates a package size of 100 tablets, includes storage instructions, manufacturing details by Alkem Laboratories Ltd. (India) for BluePoint Laboratories, and displays NDC 68001-503-00 with caution to verify dispensed product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.